Affinity Asset Advisors »

X4 Pharmaceuticals shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $580k 145k 4.00

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
Vanguard Group
Braidwell
Nantahala Capital Management
BVF
Samsara BioCapital
Rosalind Advisors
Deep Track Capital
Woodline Partners
Geode Capital Management
Kingdon Capital Management
Goldman Sachs Group
Point72 Asset Management
Stonepine Capital Management
Stempoint Capital

View all funds holding X4 Pharmaceuticals